RPS6KB2 and colorectal cancer: In particular, transfection of LoVo colorectal cancer cells with an miR-1273g-3p inhibitor remarkably reduced the mRNA and protein levels of ERBB4, PIK3R3, mTOR, and S6K2 [43].